Bioorganic studies in AIDS: Synthetic antifungals against Pneumocystiscarinii based on the multivalency concept

International Journal of Molecular Sciences

Volumn 3, Issue 11-12, 2002, Pages 1145-1161

  Peng, Langu ^a   Chen, Cunxiang ^a   Gonzalez, Christian R ^a   Balogh Nair, Valeria ^a  

^a CITY COLLEGE OF NEW YORK   (United States)

Author keywords

AIDS; Antifungals; Multivalency in drug design; Nitrones; Nitronyl nitroxides; Opportunistic infections; Oxaziridines; Pneumocystis carinii; Sulfonyloxaziridines

Indexed keywords

ANTIFUNGAL AGENT; BISOXAZIRIDINE DERIVATIVE; COTRIMOXAZOLE; NITRONE DERIVATIVE; NITRONYL NITROXIDE; NITROXIDE DERIVATIVE; OXAZIRIDINE DERIVATIVE; RADICAL; SULFONYLOXAZIRIDINE; TRISOXAZIRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR INTERACTION; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII;

INSERTION SEQUENCES; PNEUMOCYSTIS CARINII;

EID: 0347474901     PISSN: 14220067     EISSN: None     Source Type: Journal    
DOI: 10.3390/i3111145     Document Type: Article

References (33)

1. UNAIDS. Report on the Global HIV/AIDS Epidemic 2000. XIII International AIDS Conference, Durban, South Africa, 2000.
2. De Clercq, E. Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med. Chem. 1995, 38, 2491-2517.
3. Pomerantz, R. J. Primary HIV-1 resistance. J. Am. Med. Assoc. 1999, 282, 1177-1179.
4. Blower, S. M.; Aschenbach, A. N.; Gershengorn, H. B.; Kahn, J. O. Predicting the unpredictable: Transmission of drug-resistant HIV. Nature Medicine, 2001, 7, 1016-1020.
5. Littman, D. R. Chemokine receptors: keys to AIDS pathogenesis? Cell 1998, 93, 677-680.
6. Saunders, J.; Tarby, C. M. Opportunities for novel therapeutic agents acting at chemokine receptors. Drug Discovery Today 1999, 4, 80-92.
7. Baba, M.; Nishimura, O.; Kanzaki, N.; Okamoto, M.; Sawada, H.; Iizawa, Y.; Shiraishi, M.; Aramaki, Y.; Okonogi, K.; Ogawa, Y.; Meguro, K.; Fujino, M. A small molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. USA 1999, 96, 5698-5703.
8. Palani, A.; Shapiro, S.; Clader, J. W.; Greenlee, W. J.; Cox, K.; Strizki, J.; Endres, M.; Baroudy, B. M. J. Med. Chem. 2001, 44, 3339-3342.
9. Finke, P.E.; Meurer, L. C.; Oates, B.; Mills, S. G.; MacCoss, M.; Malkowitz, M.; Springer, M. S.; Daugherty, B. L.; Gould, S. L.; DeMartino, J. A.; Siciliano, S. J.; Carella, A.; Carver, G.; Holmes, K.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Schleif, W. A.; Emini, E. A. Antagonists of the human CCR5 receptor as anti-HIV -1-agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N- (phenylsulfonyl)amino]-4-(piperidinyl-1-yl)butanes. Bioorg. Med. Chem. Lett. 2001, 11, 265-270.
10. Balogh-Nair, V.; Brathwaite, C. E.; Chen, C. X.; Gonzalez, C. R.; Finberg, R. W. Synthesis and anti-HIV activity of macrocyclic chemokine mimics. To be submitted to J. Med. Chem; Reduction of HIV-1's infectivity by chemokine mimics. Presented at the Gordon Conference: Chemotherapy of AIDS, Ventura, CA, 1997.
11. Balogh-Nair, V.; Brathwaite, C. E.; Chen, C. X.; Gonzalez, C. R.; Finberg, R. W. Synthesis and anti-HIV activity of macrocyclic chemokine mimics. To be submitted to J. Med. Chem; Reduction of HIV-1's infectivity by chemokine mimics. Presented at the Gordon Conference: Chemotherapy of AIDS, Ventura, CA, 1997.
12. Balter, M. AIDS researchers negociate tricky slopes of science. Science, 1998, 280, 825-826.
13. Kovacs, J. A.; Heimentz, J. W.; Macher, A. M.; Stover, D.; Murray, H. W.; Shelhamer, J.; Lane, H. C.; Urmarcher, C.; Honig, C.; Longo, D.; Parker, M. M.; Natanson, J.E.; Parillo, J. E.; Fauci, A. S.; Pizzo, P. A.; H. Masur, H. Pneumocystis carinii pneumonia: a comparison between patients with acquired immunodeficiency syndrome and patients with other immunodeficiencies, Ann. Int. Med. 1984, 100, 663-671.
14. Sternberg, S. The emerging fungal threat. Science, 1994, 266, 1632-1634.
15. Physicians' Desk Reference, Medical Economics Data Production Company, Mont Vale, NJ, 2001; pp 1442-1446.
16. Greenidge, P. A.; Jenkins, T. C.; Neidle, S. DNA minor groove recognition properties of pentamidine and its analogs: A molecular modeling study. Mol. Pharmacol. 1993, 43, 982-988.
17. Balogh-Nair, V. Oxidoredox suppression of fungal infections by novel pharmacophores. In Advances in Bioorganic Chemistry. The Biology - Chemistry Interface. Snyder, J. K.; Cooper, R., Eds.; Marcel Dekker Inc., 1999, Chapter 12, pp 311-349.
18. Brathwaite, C. E.; Chen, C. X.; Balogh-Nair, V. Novel oxygenated macrocycles as oxygenase mimics. Indian J. Chem. 1992, 31B, 810-812.
19. Mammen, M.; Choi, S-K.; Whitesides, G. M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 1998, 37, 2754-2794.
20. Borman, S. Multivalency: Strength in numbers. Enormous affinity enhancements afforded by multivalent binding may have implications for drug design. C&N, 2000, October 9, pp 47-53.
21. Moncada, S.; Palmer, R. M. J.; Higgs, E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991, 43, 109-142.
22. Granger, D. L.; Perfect, J. R.; Durack, D. T. Macrophage-mediated fungistatis in vitro: Requirements for intracellular and extracellular cytotoxicity. J. Immunol. 1986, 136, 672-680.
23. Alspaugh, J.A. Granger, D. L. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infection and Immunity 1991, 59, 2291-2296.
24. Zhu, L.; Gunn, C.; Beckman, J. S. Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 1992, 298, 452-457.
25. Malawista, S. E.; Montgomery, R. R.; Van Blaricom, G. Evidence for reactive nitrogen intermediates in killing of Staphylococci by human neutrophil cytoplasts. J. Clin. Invest. 1992, 90, 631-636.
26. Freman, J. L. R.; Kreck, M. L.; Uhlinger, D. J.; Lambeth, J. D. Ras-effector homologue region on Rac regulates protein associations in the neutrophil respiratory burst oxidase complex. Biochemistry 1994, 33, 13431-13435.
27. Rundel, W. Methoden zur Herstellung und Umwandlung von Oxaziridinen, In Methoden der Organischen Chemie. Houben, J.; Weyl, Th.; Muller, E., Eds. Thieme: Stuttgart, 1988; band X/4. p 449.
28. 13CH coupling constants in oxaziridines. J. Am. Chem. Soc. 1972, 94, 8501-854.
29. Cudic, M.; Herrman, R. Multinuclear magnetic resonance study of oxaziridines. Magn. Reson. Chem. 1993, 31, 461-467.
30. Burger's Medicinal Chemistry and Drug Discovery. Volume 1. Principles and Practice. Wolff, M. E., Ed.; Wiley: New York, 1995; Vol. 1, Chapter 1, p 15.
31. Bartlett, M. S.; Edlind, T. D.; Lee, C-H.; Dean, R.; Queener, S. F.; Shaw, M. M.; Smith, J. W. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob. Agents & Chemother. 1994, 38, 1834-1837.
32. Tahmasebbi, D. C.; Sasaki, T. Synthesis of a three-helix bundle protein by reductive amination. J. Org. Chem. 1994, 59, 728-731.
33. Peng, L., Ph.D. thesis, The City University of New York, 1999.